| Yvonne Wang, MD | |
|
40 Temple St, New Haven, CT 06510-2715 | |
| (203) 785-2020 | |
| Not Available |
| Full Name | Yvonne Wang |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 9 Years |
| Location | 40 Temple St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679953863 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0120X | Ophthalmology - Cornea And External Diseases Specialist | 66516 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells.
Results of a small Johns Hopkins Children's Center study show that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage — an often reversible but sometimes serious complication.
The American Center for Law and Justice (ACLJ), which represents two non-profit organizations that operate numerous pro-life crisis pregnancy centers in New York City, today asked the U.S. Supreme Court to take a case in which a federal appeals court has upheld portions of a New York City law that targets pro-life pregnancy centers, making it difficult for them to exercise their First Amendment rights.
Medgenics, Inc., the developer of Biopump, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Israel's Ministry of Health (MOH) has approved two Phase I/II clinical trials to assess the safety and efficacy of INFRADURE in patients with hepatitis C.
A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today it was named a winner of Red Herring's Top 100 North America award, a prestigious honor recognizing leading private companies from North America, which celebrated these startups' innovations and technologies across their respective industries.
› Verified 6 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells.
Results of a small Johns Hopkins Children's Center study show that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage — an often reversible but sometimes serious complication.
The American Center for Law and Justice (ACLJ), which represents two non-profit organizations that operate numerous pro-life crisis pregnancy centers in New York City, today asked the U.S. Supreme Court to take a case in which a federal appeals court has upheld portions of a New York City law that targets pro-life pregnancy centers, making it difficult for them to exercise their First Amendment rights.
Medgenics, Inc., the developer of Biopump, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Israel's Ministry of Health (MOH) has approved two Phase I/II clinical trials to assess the safety and efficacy of INFRADURE in patients with hepatitis C.
A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today it was named a winner of Red Herring's Top 100 North America award, a prestigious honor recognizing leading private companies from North America, which celebrated these startups' innovations and technologies across their respective industries.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yvonne Wang, MD 40 Temple St, New Haven, CT 06510-2715 Ph: (203) 785-2020 | Yvonne Wang, MD 40 Temple St, New Haven, CT 06510-2715 Ph: (203) 785-2020 |
News Archive
Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells.
Results of a small Johns Hopkins Children's Center study show that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage — an often reversible but sometimes serious complication.
The American Center for Law and Justice (ACLJ), which represents two non-profit organizations that operate numerous pro-life crisis pregnancy centers in New York City, today asked the U.S. Supreme Court to take a case in which a federal appeals court has upheld portions of a New York City law that targets pro-life pregnancy centers, making it difficult for them to exercise their First Amendment rights.
Medgenics, Inc., the developer of Biopump, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Israel's Ministry of Health (MOH) has approved two Phase I/II clinical trials to assess the safety and efficacy of INFRADURE in patients with hepatitis C.
A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today it was named a winner of Red Herring's Top 100 North America award, a prestigious honor recognizing leading private companies from North America, which celebrated these startups' innovations and technologies across their respective industries.
› Verified 6 days ago
Dr. Michael Ehrlich, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 40 Temple Street, Yale Ophthalmology, New Haven, CT 06510 Phone: 203-395-7949 Fax: 203-785-7090 | |
Dr. Susan Hall Forster, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 55 Lock Street, New Haven, CT 06520 Phone: 203-432-0076 Fax: 203-432-7289 | |
Dr. Wayne Ian Larrison, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 46 Prince St, Suite 402a, New Haven, CT 06519 Phone: 203-787-6161 Fax: 203-776-0300 | |
Philip Carl Palmisano, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 800 Howard Ave, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2140 Fax: 203-785-6414 | |
Dr. Ji Liu, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Temple St, Suite 1b, New Haven, CT 06510 Phone: 203-785-3360 Fax: 203-785-7090 | |
Dr. Aryan Shayegani, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 40 Temple St, Suite 3-a, New Haven, CT 06510 Phone: 203-785-2020 Fax: 203-785-6123 | |
Dr. David Silverstone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Temple St, Suite 5b, New Haven, CT 06510 Phone: 203-789-2020 Fax: 203-562-6028 |